Form 4: BioAtla Director Scott Andrew Smith Reports Tax Withholding Transaction
SEC Form 4 Filing
Director Scott Andrew Smith reports a transaction involving the withholding of BioAtla shares to cover tax obligations related to vested restricted stock units.
Summary
- On July 31, 2024, BioAtla Director Scott Andrew Smith reported a transaction on Form 4.
- The transaction involved the withholding of 2,181 shares of common stock by BioAtla to satisfy income tax obligations related to the vesting and net settlement of previously reported restricted stock units.
- The price per share for the withholding was $1.81.
- Following the transaction, Smith beneficially owns 300,231 shares of BioAtla common stock directly.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax withholding, which has a neutral sentiment.
Industry Context
Form 4 filings are a routine part of compliance for corporate insiders and provide transparency into their transactions in company stock.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax withholding.
Key Dates
| Date | Description |
|---|---|
| 07/31/2024 | Date of transaction (tax withholding). |
| 08/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.